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after the exposure to antibiotics, peaking in the immediate
post-therapy period. In conclusion, decrease of side-effects
could be the main beneﬁt of shorter antibiotic treatment.
doi:10.1016/j.ijid.2010.02.155430 14
ears (amplitude 9 to 70). Five patients were male, 4
emale. All had subacute presentations and community
cquired infections. Antibiotics were not given before blood
ulture (BC) collection in only 3 of 9 patients (C.burnetii
, S.oralis 2). Mean time of antibiotics given before valve
urgery was 29± 15 days. Predisposing conditions were
nterventricular septum 1, rheumatic valvulopathy 4, pros-
hesis 3. All transesophageal echocardiograms showed major
riteria, but all cases were only clinically possible by the
odiﬁed Duke criteria. All cases were deﬁnite by surgical
nd histopathological and immunohistochemistry ﬁndings.
linical features showed fever in 4/9, new valvar regurgi-
ation in all, splenomegaly in 1/9, emboli to skin in 1/9,
levated CRP in 6/6, and elevated ESR in 5/7 patients. Two
atients died, both in refractory heart failure.
Conclusion: The gold standard to establish the etiology
f BCNE is study of the excised valves. Nearly a third of
ases of BCNE in this cardiac surgery hospital had its eti-
logy deﬁned by PCR of parafﬁn-embedded valves. This is
he ﬁrst data from Brazil relying on molecular biology of
alves for the diagnosis of BCNE, with viridans, Coxiella and
artonella documented. Of note, 7 of the 9 cases involved
.oralis underscoring antibiotics prior to BC collection as a
ajor factor in BC negativity.
oi:10.1016/j.ijid.2010.02.1552
uccessful short antibiotic treatment of childhood
neumonia - Myth or reality? (Invited Presentation)
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Understanding of the relationships between pharma-
okinetic (PK) and pharmacodynamic (PD) parameters and
acteriological and clinical outcomes of infections has
esulted in appreciation of the correlation between in vitro
otency and in vivo efﬁcacy of antimicrobial agents. PK
nd PD principles can be applied to the development of
ew antibacterials and optimising the formulation of exist-
ng agents to help address the increasing prevalence of
ntibacterial resistance. Antimicrobial agents can generally
e divided into those that have time-dependent activity,
uch as beta-lactams, and those that have concentration-
ependent activity, such as macrolides, lincosamides and
uinolones. For beta-lactams, the unbound serum con-
entration of the drug exceeding the minimum inhibitory
oncentration of the causative pathogen for 40-50% of
he dosing interval (40% for penicillins and 50% for
ephalosporins) is predictive of bacteriologic efﬁcacy and
an be used to determine a PK/PD breakpoint for speciﬁc
osing regimens. For concentration-dependent agents, the
nbound serum area-under-the-curve (AUC) to MIC ratio
xceeding 30 for macrolides, lincosamides and quinolones
s generally predictive of bacteriologic efﬁcacy and can be
sed to determine a PK/PD breakpoint for these agents.
moxicillin and amoxicillin/clavulanate are examples of
gents that have been studied and PK/PD principles appliedternational Congress on Infectious Diseases (ICID) Abstracts
o develop new and enhanced formulations, allowing these
gents to remain signiﬁcant antibacterial agent in the man-
gement of respiratory tract infections despite development
f resistance. While intrinsic and acquired resistance is
ommon in respiratory pathogens, in vitro susceptibility
an be accurately interpreted based on PK/PD parameters.
K/PD principles can be used to develop effective dosing
egimens, develop new formulations and dosage regimens,
ontribute to guideline recommendations, establish suscep-
ibility breakpoints, and validate bacteriologic outcome in
linical studies. However, PK/PD principles do not relate
o length of therapy, which is mainly inﬂuenced by disease
everity, presence of comorbid conditions and patient com-
liance.
oi:10.1016/j.ijid.2010.02.1553
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University Hospital Antwerp, Edegem-Antwerp, Belgium
Most antibiotics prescribed for outpatients are written
or treatment of respiratory tract infections. Many of these
rescriptions are necessary for curbing spread of infec-
ion and preventing development of harmful sequelae. Less
ttention has been paid to the role of duration of antibiotic
herapy to treat respiratory tract infections, particularly
neumonia in children, for the judicious use of antibiotics.
n fact, prescribing the appropriate duration of a course of
ntibiotic therapy is as important as eliminating prescrip-
ions for nonbacterial illnesses in practising judicious use of
ntibiotics.
How long is enough and how long is too much? Thera-
eutic courses need to be of sufﬁcient duration to result in
clinical cure to return patients as rapidly as possible to
ormal functioning and to prevent the progression of dis-
ase and the development of dangerous sequelae. However,
nnecessarily lengthy courses of therapy may prevent the
ealization of these treatment goals by heightening the risk
f development of bacterial resistance and side effects and
y reducing compliance with the therapeutic regimen. In
hildren, the latter is however not relevant. We investi-
ated the direct impact of antibiotic exposure on resistance
t the individual level in healthy cohorts, treated with
zithromycin, clarithromycin, or a placebo in a randomised,
ouble-blind trial. Both macrolides signiﬁcantly increased
he mean macrolide-resistant proportions of viridans strep-
ococci compared to the placebo at all time-points. Our
tudy showed that selection of resistance occurs very rapidly
